New England Biolabs and Color partner to provide COVID-19 testing to biotech workers essential to global pandemic response
February 2, 2021
Today, biotech manufacturer and supplier New England Biolabs (NEB) and Color, a leading health technology company committed to advancing public health, announced their partnership providing weekly COVID-19 testing to NEB’s US-based employees. This partnership enables NEB employees to continue their essential role in manufacturing critical materials necessary for the development of COVID-19 diagnostic tests... Read More
Antigen vs. PCR-based COVID-19 Testing: Pros & Cons
October 20, 2020
As the COVID-19 pandemic continues, new questions around different types of tests and testing models are arising – and the best choice for any given population isn’t always clear. Antigen testing and rapid point-of-care tests are facing new questions about their accuracy,... Read More
Awareness to Action: Navigating breast cancer care during the COVID-19 pandemic
October 8, 2020
During the COVID-19 pandemic, Breast Cancer Awareness Month looks a little different. For many people, routine cancer screenings have been postponed or canceled, due to concerns about the risks associated with attending in-person appointments. As always, Color observes this... Read More
19 organizations from the healthcare community unite to form COVID-19 testing industry consortium
October 1, 2020
Widespread accurate testing for SARS-CoV-2, the virus that causes COVID-19, is one critical aspect needed to limit the spread of the disease. By creating the COVID-19 Testing Industry Consortium, 19 organizations from the healthcare industry have joined forces with a goal to... Read More
With New EUA, Color’s COVID-19 self-collection kit enables public health and large private labs to increase access to testing
September 16, 2020
Color, a leading health technology company committed to advancing public health, received an emergency use authorization (EUA) from the U.S. Food and Drug Administration that enables CLIA-certified laboratories designated by Color to use its self-swab COVID-19 collection kit for... Read More
How we built our COVID-19 intake product in a week
September 14, 2020
In March, Color quickly mobilized our diagnostic genetics testing infrastructure to respond to the COVID-19 pandemic. While Color’s lab was developing our lab tests and validation, the product and engineering teams started to untangle what testing flows are needed in a... Read More
Color and researchers from Massachusetts General Hospital and the Broad Institute discover key finding to determine risk of genomic diseases
August 19, 2020
Today, the journal Nature Communications published new research, led by scientists from Color, Massachusetts General Hospital and the Broad Institute of MIT and Harvard, that sheds light on the risk of developing three diseases: coronary artery disease, breast cancer and... Read More
Modeling SARS-CoV-2 outbreaks in workplaces, universities, and other congregate settings
August 6, 2020
The SARS-CoV-2 pandemic has upended the way we work, teach, and socialize. As the pandemic continues, institutions are solving for how to bring people back on-site safely. One of the most important aspects of returning on-site is ensuring that adequate steps are taken to protect... Read More
USC Student Health begins campus-wide COVID-19 testing with Color
July 30, 2020
University of Southern California Student Health announces that it will expand COVID-19 testing as part of its overall testing strategy to help keep students, faculty and staff safe on its campuses. Beginning in August, the university will begin ramping up to a minimum of 500... Read More
Color receives emergency use authorization for unmonitored COVID-19 testing technology
July 27, 2020
Today, Color, a leading health technology company based in the Bay Area, announced it has received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration to offer COVID-19 testing without clinical monitoring. The Color test now supports unmonitored... Read More
COVID-19 symptoms analysis and clustering methods
July 16, 2020
Color recently published a press release highlighting key results from an analysis of data from over 30,000 individuals who completed a Color COVID-19 test. The press release highlighted that the majority of individuals who test positive reported mild or no symptoms, and only a... Read More
New COVID-19 test data: Majority of people who test positive for COVID-19 have mild symptoms or are asymptomatic
June 18, 2020
Today Color is releasing new data from its COVID-19 testing program that demonstrates the importance of widespread testing to reopen cities, universities, and businesses. Color has returned COVID-19 test results to more than 30,000 people, with 1.3% testing positive. The... Read MoreThe COVID-19 workforce testing plan that will help America reopen
May 11, 2020
As we start the long process of bringing America back to work, we are facing the reality that the conditions that enabled outbreaks to occur across the world remain virtually the same. The vast majority of the population is susceptible to contracting COVID-19, for which we have... Read More
Mobilizing Color’s infrastructure in response to the COVID-19 crisis
March 31, 2020
As the magnitude of the COVID-19 crisis became clear, we mobilized Color to contribute our clinical testing infrastructure and services to support the emergency response. Three weeks ago, Color began repurposing services that we have used to scale population genetics to increase... Read More
‘A milestone in lab development’: How two women pioneered automation in Color’s lab
March 19, 2020
Sophie Xu, Color’s automation technical lead, watches over the automation process in the lab. Color’s lab is committed to producing reliable and repeatable clinical results. Thousands of samples come through Color’s lab daily, and in order to ensure the samples are... Read More
Color’s women in engineering: ‘Before joining Color, it was rare to have another woman at the table.’
March 17, 2020
Mistaken for a member of the HR team by a peer. Paid less than a more junior colleague. Continuously asked out on dates by male colleagues. Accusations of promotions simply as a result of diversity quotas. Left out of meetings held at urinals where crucial decisions were made.... Read More
Color’s women in research: leading the way in population genomics
March 5, 2020
March is Women’s History Month, a month to celebrate women’s history, share stories of women having an impact on their fields, and examine how women are represented across industries. Today, Adriana Boateng-Kuffour, MS, MPH, a Principal Outcomes Researcher at Color,... Read More